Dellann Elliott Mydland on Testing Brain Tumor Tissue

Article

Dellann Elliott Mydland, from the Chris Elliott Fund, discusses the importance of testing brain tumor tissue before surgery.

Dellann Elliott Mydland, from the Chris Elliott Fund, discusses the importance of testing brain tumor tissue before surgery.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Image of a woman wearing a patterned shirt in front of a dark blue background
Photo of a woman wearing a blazer in front of an Oncology Nursing News backdrop
3 experts in this video
3 experts in this video
Photo of a white man with curly hair and in front of a blue Oncology Nursing News backdrop
Related Content
Anatomical aerial image of a person with a brain tumor

Phase 2B Glioblastoma Vaccine Trial Cleared to Continue

Russ Conroy
May 14th 2025
Article

The phase 2b SURVIVE trial of SurVaxM in newly diagnosed glioblastoma will continue as planned following an interim review by an independent safety board.

The Vitals

Jacki Garcia and Kristin Hendrickson on Navigating Patients Through Phase 0 Trials

Lindsay Fischer
July 15th 2023
Podcast

Jacki Garcia, RN, BSN, CNRN; and Kristin Hendrickson, BA, RN, discuss phase 0 trials and how they can help expedite the research process for brain cancer therapies.

Image of a pediatric patient with a headwrap with an upset face holding a teddy bear

Racial, Ethnic Disparities Present in Pediatric Brain Cancer Survival

Russ Conroy
May 8th 2025
Article

Black and Hispanic pediatric patients with high-risk neuroblastoma had significantly lower 5-year survival rates in induction and/or consolidation trials.

Line illustration of a person with lines emphasizing the brain

TLX101-CDx Given Complete Response Letter for Glioma Imaging

Chris Ryan
May 6th 2025
Article

The FDA granted a complete response letter with no safety concerns for the new drug application for TLX101-CDx’s use in glioma imaging.

Graphic image of a blue brain on a blue background

Breakthrough Designation Granted to BCB-276 for Pediatric DIPG

Chris Ryan
April 25th 2025
Article

Findings from the phase 1 BrainChild-03 trial support breakthrough designation for BCB-276 for pediatric diffuse intrinsic pontine glioma.

Image of a row of vials lined up on a counter

VXM01 Vaccine/Avelumab Displays Safety, Early Clinical Activity in GBM

Ashling Wahner
April 8th 2025
Article

VXM01 plus avelumab was tolerable and could potentially produce clinically meaningful responses in patients with recurrent glioblastoma.